Literature DB >> 32304822

COVID-19: Four Paediatric Cases in Malaysia.

K C See1, S M Liew2, David C E Ng3, E L Chew4, E M Khoo2, C H Sam4, D Sheena1, Z Zahilah Filzah1, S Y Chin1, P Y Lee1, L P Tan1, Z Farah Najwa1, S Sabrina1, W W Them1, T Saipriya1, Z A Muhammad Zamakhshari3, W K Cheah5, K Peariasamy6, P P Goh7, H Ibrahim8.   

Abstract

OBJECTIVE: This is a brief report of 4 paediatric cases of COVID-19 infection in Malaysia
BACKGROUND: COVID-19, a coronavirus, first detected in Wuhan, China has now spread rapidly to over 60 countries and territories around the world, infecting more than 85000 individuals. As the case count amongst children is low, there is need to report COVID-19 in children to better understand the virus and the disease. CASES: In Malaysia, until end of February 2020, there were four COVID-19 paediatric cases with ages ranging from 20 months to 11 years. All four cases were likely to have contracted the virus in China. The children had no symptoms or mild flu-like illness. The cases were managed symptomatically. None required antiviral therapy. DISCUSSION: There were 2 major issues regarding the care of infected children. Firstly, the quarantine of an infected child with a parent who tested negative was an ethical dilemma. Secondly, oropharyngeal and nasal swabs in children were at risk of false negative results. These issues have implications for infection control. Consequently, there is a need for clearer guidelines for child quarantine and testing methods in the management of COVID-19 in children.
Copyright © 2020 The Author(s). Published by Elsevier Ltd.. All rights reserved.

Entities:  

Keywords:  COVID-19; Coronavirus; Epidemiology; Outbreak; Paediatric; epidemic; nCoV

Mesh:

Year:  2020        PMID: 32304822      PMCID: PMC7158792          DOI: 10.1016/j.ijid.2020.03.049

Source DB:  PubMed          Journal:  Int J Infect Dis        ISSN: 1201-9712            Impact factor:   3.623


COVID-19, a coronavirus first detected in Wuhan in December 2019, has now spread rapidly to over 30 countries infecting more than 70000 persons. The largest study to date found that out of 44672 confirmed cases registered in China’s Infectious Disease Information System up to 11 February 2020, there were 416 (0.9%) between the ages of 0-9 years and 549 (1.2%) between the ages of 10-19 years (The Novel Coronavirus Pneumonia Emergency Response Epidemiology Team, 2020). There was one reported death in the category of 10-19 years. This seemed to indicate that the number of children infected was much less and their prognosis better compared with the adults. However, there is limited literature on COVID-19 in children. We report 4 confirmed cases in children that were diagnosed and treated in Malaysia. The cases ranged from 20 months to 11 years of age [Table 1 ]. All four cases were likely to have contracted the virus in China. Of these, only one was a Malaysian who had visited Wuhan for the Chinese New Year festival as his mother originated from Wuhan. The patients were mostly asymptomatic or had mild symptoms. Case 1 was asymptomatic until day 17 when fever and diarrhoea occurred. Nevertheless, the child’s swabs were negative at that time. Case 2 had intermittent fever and upper respiratory tract symptoms. Case 3 was asymptomatic throughout. Case 4 had a mild cough and wheeze that responded well to salbutamol inhaler. None of the children required treatment with anti-virals. It is unknown why children with COVID-19 appeared to have milder disease. The adults may be more susceptible due to pre-existing conditions such as hypertension, diabetes, heart disease or smoking which could weaken their ability to ward off infections. The adults may also be more susceptible to an immune overdrive that leads to acute respiratory distress syndrome (ARDS). The mild or asymptomatic presentation in children may have impacted on infection control as they could be missed by existing surveillance. Further research needs to be carried out on the paediatric population to explore this matter.
Table 1

Demographic and Clinical data.

Case 1Case 2Case 3Case 4
Age20 months4 years9 years11 years
GenderMaleFemaleMaleMale
EthnicityChineseChineseChineseChinese
NationalityChinaChinaMalaysiaChina
Method of detectionContact tracingSelf-presentationScreening for Wuhan evacueeContact tracing
Date of infectionLeft Wuhan on 20 January 2020Left Foshan on 19 January 2020.Left Wuhan on 4 February 2020Left Wuhan on 20 January 2020
Date of detection24 January 202026 January 20204 February 202024 January 2020
Date of confirmation25 January 202026 January 20204 February 202025 January 2020
Site of detectionHotel, JohorEmergency Dept, HospitalKuala Lumpur International AirportHotel, Johor
Site of treatmentHospital Sungai BulohHospital Sultanah Maliha, LangkawiHospital SerembanHospital Sungai Buloh
SymptomsAsymptomatic until D17 when he developed mild fever and diarrhoeaRunny nose and cough for 2-4 weeks, intermittent fever between 25- 30 JanuaryAsymptomaticMild cough for one day. Later diagnosed clinically as asthma
Method of diagnosisNasopharyngeal and throat swabs taken for PCRNasal swabs taken for PCRNasopharyngeal and throat swabs taken for PCRNasopharyngeal and throat swabs taken for PCR
Swabs negative on10, 11 and 12 February 20201 and 3 February 202013 and 17 February 202010, 11 and 12 February 2020
Other investigationsRenal and liver profile normal. Rectal swab negative for COVID-19Blood culture showed no growth. No other investigations. Nasal swab also positive for influenza AChest X- ray showed right perihilar opacitiesChest X- ray showed perihilar opacities
TreatmentParacetamol and Oral Rehydration SaltsParacetamol, oral penicillin V, loratadineNoneMDI salbutamol prn
Quarantine precautionsQuarantined with family in non-negative pressure roomQuarantined with younger sibling and parents in negative pressure roomQuarantined with father in negative pressure roomQuarantined with family in non-negative pressure room
PPE for staffPPE for staffPPE for staffPPE for staff
Demographic and Clinical data. There were issues regarding the care of paediatric cases that should be highlighted. Firstly, should an infected child under quarantine be separated from parents who were tested negative? Case 1 and Case 4 were brothers who were quarantined with their grandmother who was tested positive and their mother who was initially tested negative but later tested positive. The mother was advised regarding the high risk of being infected but she insisted on being quarantined together with her mother in law and children. Even though the patients were given masks, they may not have fully complied with the proper protocol. Case 2 was quarantined together with a younger sibling and parents who were well and had negative swabs for COVID-19 throughout their stay. The CDC guidance for the prevention and control of influenza in the peri- and post-partum settings recommends temporary separation of an ill mother and her child (Centers for Disease Control and Prevention, 2020). However, this separation may lead to a negative impact on both the child and the mother. The CDC states that the risks and benefits should be discussed with the mother and decisions made in accordance with the mother’s wishes. Secondly, there are difficulties to obtain respiratory samples from paediatric patients. The 20-month-old child vomited on the doctor during the blood taking procedure. Performing throat and nasopharyngeal swabs are technically more difficult in paediatric patient and may sometimes require more than one healthcare provider to be fully gowned up in the room to assist the procedure. The Malaysian protocol states that the cases would be considered negative if two consecutive swabs are negative. However, some of the throat and nasopharyngeal swabs that were positive in Case 1 and Case 4 turned negative in testing and later reverted to positive [Table 2 ]. The early negative results were likely false negatives from sampling error due to difficulty in obtaining respiratory specimens from this age group. It may be necessary to have three consecutive negative swabs before considering the patient to be fully recovered. The RT-PCR cycle threshold [CT} value gives an estimate of the viral load where the lower the CT value, the higher the viral load (Wishaupt et al., 2017). However, the relationship between viral load and disease severity is still uncertain and under research. Presently RT-PCR Ct values are not used in the clinical management of COVID-19.
Table 2

Swab results.

Case 1Case 2Case 3Case 4
OPSNPSOPSNPSOPSNPSOPSNPS
123 Jan Positive23 Jan Positive26 Jan Positive26 Jan Positive *28.014 Feb Positive4 Feb Positive23 Jan Positive23 Jan Positive
25 Feb Positive *31.55 Feb Positive *31.041 Feb Negative1 Feb Negative7 Feb Positive7 Feb Positive *32.055 Feb Negative5 Feb Negative
38 Feb Negative8 Feb Negative3 Feb Negative3 Feb Negative10 Feb Positive10 Feb Positive *35.648 Feb Positive *40.648 Feb Negative
49 Feb Negative9 Feb Positive *39.9713 Feb Negative13 Feb Negative9 Feb Positive *39.059 Feb Negative
510 Feb Negative10 Feb Positive *37.5517 Feb Negative17 Feb Negative10 Feb Negative10 Feb Positive *36.42
611 Feb Negative11 Feb Negative11 Feb Negative11 Feb Negative
712 Feb Negative12 Feb Negative12 Feb Negative12 Feb Negative

RT-PCR Ct Value, OPS : oropharyngeal swab, NPS : nasopharyngeal swab

Swab results. RT-PCR Ct Value, OPS : oropharyngeal swab, NPS : nasopharyngeal swab There has been an expert consensus statement from China on the diagnosis, treatment and prevention of COVID-19 on the 7th of February 2020 (Shen et al., 2020). Most of the measures taken in these 4 cases agreed with the statement except for traditional treatments that were not used in our hospitals. We aimed to share the findings of the 4 cases in order to highlight the relatively mild symptoms of COVID-19 in children and the difficulties encountered in the care of paediatric patient affected by the illness.

Conflict of interest

None.

Funding source

None.

Ethical approval

This short communication has obtained the permission to publish by the Director General of Health, Ministry of Health, Malaysia.
  2 in total

1.  Pitfalls in interpretation of CT-values of RT-PCR in children with acute respiratory tract infections.

Authors:  Jérôme O Wishaupt; Tjeerd van der Ploeg; Leo C Smeets; Ronald de Groot; Florens G A Versteegh; Nico G Hartwig
Journal:  J Clin Virol       Date:  2017-02-24       Impact factor: 3.168

Review 2.  Diagnosis, treatment, and prevention of 2019 novel coronavirus infection in children: experts' consensus statement.

Authors:  Kunling Shen; Yonghong Yang; Tianyou Wang; Dongchi Zhao; Yi Jiang; Runming Jin; Yuejie Zheng; Baoping Xu; Zhengde Xie; Likai Lin; Yunxiao Shang; Xiaoxia Lu; Sainan Shu; Yan Bai; Jikui Deng; Min Lu; Leping Ye; Xuefeng Wang; Yongyan Wang; Liwei Gao
Journal:  World J Pediatr       Date:  2020-02-07       Impact factor: 9.186

  2 in total
  19 in total

1.  Movement control as an effective measure against Covid-19 spread in Malaysia: an overview.

Authors:  Kuok Ho Daniel Tang
Journal:  Z Gesundh Wiss       Date:  2020-06-13

Review 2.  The novel zoonotic Coronavirus disease 2019 (COVID-19) pandemic: Health perspective on the outbreak.

Authors:  M Mazinani; B J Rude
Journal:  J Healthc Qual Res       Date:  2020-10-14

3.  Clinical Characteristics of Asymptomatic and Symptomatic Pediatric Coronavirus Disease 2019 (COVID-19): A Systematic Review.

Authors:  Sojung Yoon; Han Li; Keum Hwa Lee; Sung Hwi Hong; Dohoon Kim; Hyunjoon Im; Woongchan Rah; Eunseol Kim; Seungyeon Cha; Jinho Yang; Andreas Kronbichler; Daniela Kresse; Ai Koyanagi; Louis Jacob; Ramy Abou Ghayda; Jae Il Shin; Lee Smith
Journal:  Medicina (Kaunas)       Date:  2020-09-15       Impact factor: 2.430

4.  Epidemiology of COVID-19 infection in young children under five years: A systematic review and meta-analysis.

Authors:  Mejbah Uddin Bhuiyan; Eunice Stiboy; Md Zakiul Hassan; Mei Chan; Md Saiful Islam; Najmul Haider; Adam Jaffe; Nusrat Homaira
Journal:  Vaccine       Date:  2020-12-05       Impact factor: 3.641

5.  Risk profiles of severe illness in children with COVID-19: a meta-analysis of individual patients.

Authors:  Bo Zhou; Yuan Yuan; Shunan Wang; Zhixin Zhang; Min Yang; Xiangling Deng; Wenquan Niu
Journal:  Pediatr Res       Date:  2021-03-22       Impact factor: 3.756

6.  SARS-COV-2 infection in children and newborns: a systematic review.

Authors:  Ilaria Liguoro; Chiara Pilotto; Margherita Bonanni; Maria Elena Ferrari; Anna Pusiol; Agostino Nocerino; Enrico Vidal; Paola Cogo
Journal:  Eur J Pediatr       Date:  2020-05-18       Impact factor: 3.860

7.  Occurrence and transmission potential of asymptomatic and presymptomatic SARS-CoV-2 infections: A living systematic review and meta-analysis.

Authors:  Diana Buitrago-Garcia; Dianne Egli-Gany; Michel J Counotte; Stefanie Hossmann; Hira Imeri; Aziz Mert Ipekci; Georgia Salanti; Nicola Low
Journal:  PLoS Med       Date:  2020-09-22       Impact factor: 11.069

8.  SARS-CoV-2 testing and outcomes in the first 30 days after the first case of COVID-19 at an Australian children's hospital.

Authors:  Laila F Ibrahim; Shidan Tosif; Sarah McNab; Samantha Hall; Hyun Jung Lee; Stuart Lewena; Andrew J Daley; Nigel W Crawford; Andrew C Steer; Penelope A Bryant; Franz E Babl
Journal:  Emerg Med Australas       Date:  2020-06-23       Impact factor: 2.279

9.  What we know so far about Coronavirus Disease 2019 in children: A meta-analysis of 551 laboratory-confirmed cases.

Authors:  Linjie Zhang; Tyele G Peres; Marcus V F Silva; Paulo Camargos
Journal:  Pediatr Pulmonol       Date:  2020-06-10

Review 10.  Coronavirus global pandemic: An overview of current findings among pediatric patients.

Authors:  Evanthia Perikleous; Aggelos Tsalkidis; Andrew Bush; Emmanouil Paraskakis
Journal:  Pediatr Pulmonol       Date:  2020-10-07
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.